Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
The Lancet ( IF 168.9 ) Pub Date : 2017-12-01 , DOI: 10.1016/s2213-2600(17)30430-7 Toby M Maher , Eunice Oballa , Juliet K Simpson , Joanne Porte , Anthony Habgood , William A Fahy , Aiden Flynn , Philip L Molyneaux , Rebecca Braybrooke , Hrushikesh Divyateja , Helen Parfrey , Doris Rassl , Anne-Marie Russell , Gauri Saini , Elisabetta A Renzoni , Anne-Marie Duggan , Richard Hubbard , Athol U Wells , Pauline T Lukey , Richard P Marshall , R Gisli Jenkins
The Lancet ( IF 168.9 ) Pub Date : 2017-12-01 , DOI: 10.1016/s2213-2600(17)30430-7 Toby M Maher , Eunice Oballa , Juliet K Simpson , Joanne Porte , Anthony Habgood , William A Fahy , Aiden Flynn , Philip L Molyneaux , Rebecca Braybrooke , Hrushikesh Divyateja , Helen Parfrey , Doris Rassl , Anne-Marie Russell , Gauri Saini , Elisabetta A Renzoni , Anne-Marie Duggan , Richard Hubbard , Athol U Wells , Pauline T Lukey , Richard P Marshall , R Gisli Jenkins
|
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disorder with a variable disease trajectory. The aim of this study was to assess potential biomarkers to predict outcomes for people with IPF.
中文翻译：
特发性肺纤维化的上皮生物标志物签名：来自多中心PROFILE队列研究的分析。
特发性肺纤维化（IPF）是一种进展性的致命疾病，病程变化不定。这项研究的目的是评估潜在的生物标志物，以预测IPF患者的预后。
更新日期：2017-11-15
中文翻译：
特发性肺纤维化的上皮生物标志物签名：来自多中心PROFILE队列研究的分析。
特发性肺纤维化（IPF）是一种进展性的致命疾病，病程变化不定。这项研究的目的是评估潜在的生物标志物，以预测IPF患者的预后。
京公网安备 11010802027423号